Fruth Custom Packaging, a leading domestic manufacturer of medical packaging, has expanded operations to respond to increasing demand for biohazard bags and autoclave bags. Designed for healthcare, medical research, pharmaceuticals, and biotechnology industries, Fruth autoclave bags include sterilization bags for medical instruments, specimen bags for transportation of biological samples, and biohazard bags for disposal of infectious waste.
Engineered for impact and puncture resistance, Fruth autoclave bags meet the most demanding worldwide regulations for sterilization and decontamination, meeting ASTM tear resistance, impact resistance, and dart drop tests. Fruth autoclave bags are compatible with high vacuum steam, ETO gas, gamma or chemical sterilization methods, and meet all autoclaving specifications per USP 〈1211〉 Sterilization Assurance. The bags are also compliant with EPA regulations and meet WHO, CDC, and state health and safety codes.
Fruth autoclave bags are manufactured in the U.S. from 100% domestically-sourced resin with industry-leading lead times. Customizable features such as temperature indicator strips provide an additional layer of safety and compliance.
Fruth’s extensive customization capabilities allow for autoclave bags to be tailored to the specific requirements of each application. Available in a wide range of sizes and material gauges, Fruth autoclave bags can be customized with features such as gussets, resealable closures, temperature indicator strips, antistatic properties, bar coding, and custom printing.
“Our expansion reflects Fruth’s ongoing commitment to delivering U.S. made sterilization packaging to the medical and life sciences sectors,” said Jaime Read, General Manager of Fruth. “This expansion allows us to continue providing industry-best lead times and customization options.”